PAS
UTHR icon

Partnervest Advisory Services’s United Therapeutics UTHR Stock Holding History

Partnervest Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-187
Closed -$15K – 1084
2013
Q3 		$15K Hold
187
– – 0.01% 550
2013
Q2 		$12K Buy
+187
New +$12K 0.01% 563

Other funds holding UTHR

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Partnervest Advisory Services's UTHR Position: Q4 2013 in Review

Partnervest Advisory Services sold out of United Therapeutics (UTHR) in Q4 2013, closing a stake of 187 shares — an estimated $15K sold.

Partnervest Advisory Services first reported a position in UTHR in Q2 2013 and held it in 2 quarters. The position peaked at $15K in Q3 2013. 321 funds tracked by Wall St. Rank hold UTHR as of Q4 2013.

  • Partnervest Advisory Services reported no remaining United Therapeutics position as of Q4 2013 after selling out during the quarter.
  • Partnervest Advisory Services sold 187 United Therapeutics shares in Q4 2013, an estimated $15K.
  • Partnervest Advisory Services first reported a position in United Therapeutics in Q2 2013 and held it in 2 quarters.
  • Partnervest Advisory Services's United Therapeutics position peaked at $15K in Q3 2013.
  • 321 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2013.

Based on Partnervest Advisory Services's 13F filing for Q4 2013, filed 11 Feb 2014.